DC-CIK联合化疗治疗晚期非小细胞肺癌的疗效分析
张士法
【期刊名称】《中国社区医师》 【年(卷),期】2016(032)029
【摘要】Objective:To investigate the therapeutic effect of DC-CIK combined with chemotherapy in patients with advanced non-small cell lung cancer.Methods:120 patients with advanced non small cell lung cancer were selected.They were divided into two groups.The control group was treated with chemotherapy alone.The observation group was treated with DC-CIK combined with chemotherapy.The treatment effect and adverse reaction of the two groups were compared.Results:The effective rate of the observation group was significantly higher than that of the control group,and the incidence of adverse reactions was significantly
lower
than
that
of
the
control
group(P<0.05).Conclusion:DC-CIK combined with chemotherapy in the treatment of advanced non-small cell lung cancer can significantly improve the patient's treatment effect,enhance the ability to resist cancer,and reduce the incidence of adverse reactions.%目的：探讨 DC-CIK 联合化疗在晚期非小细胞肺癌中的治疗效果。方法：收治晚期非小细胞肺癌患者120例，分两组，对照组给予单纯化疗治疗，观察组给予DC-CIK联合化疗治疗，比较两组患者的治疗效果和不良反应的发生情况。结果：观察组的治疗有效率明显高于对照组，不良反应的发生率明显低于对照组(P＜0.05)。结
DC-CIK联合化疗治疗晚期非小细胞肺癌的疗效分析
